ACRO Biomedical Co., Ltd. (TPEX:6748)
Taiwan · Delayed Price · Currency is TWD 66.60
-0.40 (-0.60%)
Apr 17, 2026, 1:57 PM CST
ACRO Biomedical Market Cap
ACRO Biomedical has a market cap or net worth of 4.09 billion as of April 17, 2026. Its market cap has increased by 58.48% in one year.
Market Cap
4.09B
Enterprise Value
3.65B
Revenue
36.50M
Ranking
n/a
PE Ratio
n/a
Stock Price
66.60
Market Cap Chart
Since July 27, 2021, ACRO Biomedical's market cap has increased from 990.62M to 4.09B, an increase of 312.81%. That is a compound annual growth rate of 34.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 4.09B | 1.21% |
| Dec 31, 2025 | 4.04B | 158.32% |
| Dec 31, 2024 | 1.56B | -35.07% |
| Dec 29, 2023 | 2.41B | 135.16% |
| Dec 30, 2022 | 1.02B | 9.09% |
| Dec 30, 2021 | 938.97M | -5.21% |
| Jul 27, 2021 | 990.62M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OBI Pharma | 4.98B |
| Senhwa Biosciences | 4.87B |
| Pharmosa Biopharm | 4.83B |
| Formosa Pharmaceuticals | 4.79B |
| Medigen Biotechnology | 4.37B |
| Energenesis Biomedical CO.,LTD. | 4.37B |
| Sagittarius Life Science | 4.18B |
| BioGend Therapeutics | 3.87B |